Michael Heinrich, M.D. is currently a Professor of Medicine at Oregon Health Sciences University. He earned his medical degree in 1984 from Johns Hopkins School of Medicine in Baltimore and completed both his residency training and Hematology and Medical Oncology fellowship at OHSU. His primary research interest is in the development of novel tyrosine kinase inhibitors for treatment of human cancers. Dr. Heinrich's research includes both pre-clinical identification of novel molecular targets and testing of new agents in the laboratory and the clinic.

Christopher Corless, M.D., Ph.D., is a Professor of Pathology at Oregon Health & Science University. He completed his medical and graduate school training at Washington University, St. Louis, and his residency in Anatomic Pathology at Brigham & Women's Hospital, Boston. In addition to serving as Director of the Cancer Pathology Shared Resource for the OHSU Cancer Institute, Dr. Corless pursues research on immunohistochemical and molecular testing to novel therapeutic targets.